top of page

Welcome to BCAL Diagnostics

An Advanced Way For Breast Cancer Detection


About BCAL Diagnostics

A Leading Biotechnology Company

BCAL Diagnostics is developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, accessible and cost effective. Breast cancer is the most common cancer amongst women, and improving the effectiveness of the screening and diagnosis technology used is a high priority.


The Company

Since forming in 2010, BCAL Diagnostics has been striving to address the issues surrounding the early detection and a more accurate method of screening for breast cancer


The BCAL Test

The current breast cancer screening (BCS) market is dominated by imaging technologies such as Mammograms and Ultrasound. BCS is one of the few screening tests with broad government funding

contact us.JPG

Contact Us

For more information on BCAL Diagnostics, its projects and investment opportunities please contact us

BCAL image_1.JPG

Our Mission

BCAL Diagnostics aims to shift the paradigm in breast cancer screening and diagnosis by introducing a blood test for detection and monitoring of the disease.


The implication of such a technology could revolutionise the way we prevent and manage breast cancer by allowing a blood sample to be taken remote from the site of analysis.


Our aim is to develop technology that would allow access to more women, anywhere in the world, who could provide a blood sample, at a time and place of their convenience. Such a test would fit into a woman's routine health regime and be incorporated into their personal lifestyle.

Our Story

BCAL Diagnostics Team

At BCAL Diagnostics, we know that early diagnosis of breast cancer and early intervention will improve clinical outcomes and survivability rate for all women. BCAL Diagnostics has a dedicated team of individuals with the aim of delivering an accessible test. 

Past Events

Aus Biz TV Interview


BCAL Diagnostics has closed off a $4M pre-IPO capital raise to fund trials of its breast cancer blood test. Chairperson Jayne Shaw says it could revolutionise how we detect cancer cells.

Jan 2021

Heads Over Heels 


BCAL Diagnostics Presents at Heads Over Heels Melbourne

June 06, 2019

Contest For International Entrepreneurs


BCAL Diagnostics Wins "Win The Future" Contest For International Entrepreneurs in Oceania Programme

October 26, 2019

Sydney Knowledge Hub

Sydney uni Logo.JPG

BCAL Diagnostics partners with Sydney Knowledge Hub And Sydney Mass Spectrometry


Subscribe Form

Thanks for submitting!

bottom of page